Sandra Calvin
Fortune : 3 M $ au 31/08/2026
Fortune : 3 M $ au 31/08/2026
Sandra Calvin is currently Chief Accounting Officer & Senior Vice President at Travere Therapeutics, Inc., a position held since 2014.
Ms. Calvin completed undergraduate studies at San Diego State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 42 353 ( 0,05 % ) | 3 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/12/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 2 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national